Bristol-Myers Squibb Stops Trial After Reaching Goal Ahead of Schedule
iStock/Thinkstock(PRINCETON, N.J.) — Bristol-Myers Squibb has stopped one of its studies early because it reached its goal ahead of schedule. A study of the drug Opdivo by Bristol-Myers Squibb was halted six months early after researchers concluded the drug was able Read More